Acceleron Pharma

Investors & Media

Investors & Media

Acceleron is a commercial-stage biopharma based in Cambridge, Massachusetts. We are guided by deep scientific expertise in the TGF-beta superfamily of biology and dedicated to the discovery and development of life-changing medicines for patients with serious and rare diseases. Our commitment to patients has led us to bring a therapy for the treatment of anemia associated with certain hematologic disorders to market in partnership with Bristol Myers Squibb and driving us toward making a lasting impact in pulmonary disease. Learn more about our clinical pipeline here.

Acceleron Pharma Inc. (NASDAQ: XLRN)

Volume: 3:29 PM EDT on Oct 25, 2020

Data Provided by Refinitiv. Minimum 15 minutes delayed.